Other languages Neuronetics, Inc.

Equities

STIM

US64131A1051

Market Closed - Nasdaq Other stock markets 16:00:00 2024-04-26 EDT			5-day change	1st Jan Change
3.49 ^USD	-0.85%		-8.16%	+20.34%

04-10	Neuronetics, Inc. Announces the Publication of Significant Clinical Findings in Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation	CI
03-28	Neuronetics, Inc. Announces John K. Bakewell, Joseph H. Capper and Dr. Wilfred E. Jaeger Not Stand for Reelection to the Board	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Neuronetics, Inc. Announces the Publication of Significant Clinical Findings in Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation	04-10
Neuronetics, Inc. Announces John K. Bakewell, Joseph H. Capper and Dr. Wilfred E. Jaeger Not Stand for Reelection to the Board	03-28
Neuronetics Gets US FDA Clearance for Treatment of Adolescents with Depression; Shares Rise	03-25
Neuronetics, Inc. Announces Clearance from the U.S. Food and Drug Administration for NeuroStar Advanced Therapy	03-25
Neuronetics, Inc. Announces 5-Year Exclusive Partnership with Transformations Care Network	03-07
Neuronetics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	03-05
Neuronetics, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024	03-05
Neuronetics Launches Latest Evolution in Its Trakstar® Patient Data Management System	02-12
Top Premarket Gainers	01-25
Neuronetics, Inc. Revises Earnings Guidance for the Fourth Quarter and Full Year of 2023	01-08
Neuronetics Receives 510(K) Clearance for Neurosite Coil Placement Accessory	12-18
Neuronetics, Inc. Elevates Depression Treatment with Cutting-Edge Technology Advancements	11-13
Neuronetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-07
Neuronetics, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2023	11-07
Neuronetics Draws Down Remaining $22.5 Million From SLR Capital Credit Facility	23-10-03
Neuronetics, Inc. Announces the Launch of the NeuroStar Voices Portal	23-09-12
Neuronetics, Inc. Revolutionizes Patient Communication and Provider Support Through Its Exclusive TrakStar Platform	23-08-14
Neuronetics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08
Neuronetics, Inc. Provides Revenue Guidance for the Third Quarter of 2023	23-08-08
Neuronetics, Inc. Revises Revenue Guidance for the Year Full Year 2023	23-08-08

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Neuronetics, Inc.

Equities

STIM

US64131A1051

Other languages

Filters